News Sentiment

2526 sentiment intelligence

Hangzhou Diagens Biotechnology Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 58 Balanced news tone 4 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 325.40 Week of 12 Jun 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

71/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+3.3% over one week, +8.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Ribo, Diagens tally 2 Hong Kong biotech, medtech IPOs in Q1 2026

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 71/100 classification
One-week reaction 3.3% Price confirming higher
Trend fit Trend inactive 8.3% over four weeks
Fair value 6.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
BioWorld News 1
Market source 1
thebambooworks.com 1
Pandaily 1

Event Lens

What the news is about

Classified themes
Market update 3
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4